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Abstract
Background: Attention deficit hyperactivity disorder is a behavioral syndrome of childhood characterized by
inattention, hyperactivity and impulsivity. There were many etiological theories showed dysfunction of some brain
areas that are implicated in inhibition of responses and functions of the brain. Minerals like zinc, ferritin,
magnesium and copper may play a role in the pathogenesis and therefore the treatment of this disorder.
Objective: This study aimed to measure levels of zinc, ferritin, magnesium and copper in children with attention
deficit hyperactivity disorder and comparing them to normal.
Methods: This study included 58 children aged 5-15 years with attention deficit hyperactivity disorder attending
Minia University Hospital from June 2008 to January 2010. They were classified into three sub-groups: sub-group I
included 32 children with in-attentive type, sub-group II included 10 children with hyperactive type and sub-group
III included 16 children with combined type according to the DSM-IV criteria of American Psychiatric Association,
2000. The control group included 25 apparently normal healthy children.
Results: Zinc, ferritin and magnesium levels were significantly lower in children with attention deficit hyperactivity
disorder than controls (p value 0.04, 0.03 and 0.02 respectively), while copper levels were not significantly different
(p value 0.9). Children with inattentive type had significant lower levels of zinc and ferritin than controls (p value
0.001 and 0.01 respectively) with no significant difference between them as regards magnesium and copper levels
(p value 0.4 and 0.6 respectively). Children with hyperactive type had significant lower levels of zinc, ferritin and
magnesium than controls (p value 0.01, 0.02 and 0.02 respectively) with no significant difference between them as
regards copper levels (p value 0.9). Children with combined type had significant lower levels of zinc and
magnesium than controls (p value 0.001 and 0.004 respectively) with no significant difference between them as
regards ferritin and copper levels (p value 0.7 and 0.6 respectively).
Conclusions: Children with attention deficit hyperactivity disorder had lower levels of zinc, ferritin and magnesium
than healthy children but had normal copper levels.
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Background
Attention deficit hyperactivity disorder (ADHD) is a
behavioral syndrome of childhood characterized by per-
vasive and impairing symptoms of inattention, hyperac-
tivity and impulsivity of early onset and it causes
significant functional impairment [1]. The worldwide
pooled prevalence of this disorder was 5.29% [2], and
many children continue to display significant symptoms
throughout adolescence and adulthood [3]. The causes of
attention deficit hyperactivity disorder were unknown.
There were many etiological theories on the dysfunction
of some brain areas that are implicated in inhibition of
responses and functions of the brain [4-6]. Zinc plays an
important role in the structure and function of the brain
[7,8]. Iron and copper serve as cofactors in the synthesis
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involved in the enzymes necessary for neurotransmitters
release, as well as protecting neuronal cell membranes
[9-11]. Changes in these minerals’ l e v e l sm a yp l a yar o l e
in the pathogenesis and therefore the treatment of this
disorder.
Aim of the work
This study aimed to measure levels of zinc, ferritin,
magnesium and copper in children with attention deficit
hyperactivity disorder and compare them with normal
healthy children.
Methods
This study included 58 children aged 5-15 years with
attention deficit hyperactivity disorder attending Minia
University Hospital from June 2008 to January 2010 with a
mean age 8.6 ± 1.8 years. They were classified into three
sub-groups: sub-group I included 32 children with in-
attentive type, sub-group II included 10 children with
hyperactive type and sub-group III included 16 children
with combined type according to the DSM-IV criteria of
American Psychiatric Association, 2000 [1]. The control
group included 25 apparently normal healthy children, 12
males (48%) and 13 females (52%) matched the study
group in age, sex and socioeconomic state. Conner’s Rat-
ing Scales were used in discriminating between children
with ADHD and controls as well as severity of ADHD.
Children with co-morbid neurological disorders, with
chronic organic diseases as blindness or deafness, history
of significant head trauma, history of perinatal asphyxia,
significant hyperbilirubinemia or encephalitis and severely
anemic children were excluded from this study and no
medications were given at least one month prior to the
study.
Blood Samples
A blood sample of 2 mls were withdrawn by venipunc-
ture after wrapping the skin by alcohol 70% and placed
into a pyrogen-free tube for complete blood count.
Another 2 mls of blood were withdrawn and centrifuged
for serum separation and stored at - 70 degrees for other
bioelements assay.
A colormetric test without desproteinization (SPIN-
REACT) was used for zinc and copper assay. For ferritin
assay a Direct ELISA Kit....The EiAsy TM Way was used.
A colorimetric method was used for magnesium assay,
and the coulter (Sysmex) system was used for hemoglo-
bin assay [12-14].
All procedures were in accordance with the current
revision of the Helsinki Declaration [15]. The parents or
guardians of all children had to give informed consent
to participate in the study. Patients whose parents or
guardians refused to consent were excluded from the
study.
Statistical analysis
Values are given as means ± SD, range or as the number
of subjects and proportions. The Student t test was used
for group comparisons of normally distributed variables,
and the Mann-Whitney U test and Wilcoxon signed-rank
test were used for comparison of variables with skewed
distribution. Pearson’s test was used to calculate the cor-
relation coefficient to describe associations between vari-
ables. One-way a nova test was used for analysis of
biochemical variables. Both the independent sample t-
test and chi-square tests were used to calculate p-value.
P < 0.05 was considered significant. Analyses were per-
formed using the SPSS software package (SPSS V 8.0 for
Windows).
Results
Patients and controls were comparable with respect to
age, sex and residence. Paternal and/or maternal smok-
ing and positive family history of attention deficit hyper-
activity disorder were significantly higher in patients
than controls (p = 0.04 and p = 0.007 respectively)
(Table 1).
Significant differences between patients and controls
were present as regards to hemoglobin, zinc, ferritin and
magnesium levels, with lower levels of them in patients
than controls (p = 0.04, p = 0.04, p = 0.03 and p = 0.02
respectively). Copper levels were not significantly differ-
ent (p = 0.9) (Table 2)
There were no significant differences between patients
subgroups as regards to hemoglobin, zinc, ferritin and
copper levels (p=0 . 0 6 ,p=0 . 5 ,p=0 . 1a n dp=0 . 6
respectively). Only magnesium levels were lower in both
hyperactive and combined sub-groups than inattentive
sub-group (p = 0.01). (Figure 1)
In patients, no significant correlations were found
between any one of bioelements studied and others
(Figures 2, 3, 4, 5).
Discussion
In this study, zinc levels were significantly lower in chil-
dren with attention deficit hyperactivity disorder than
controls. This was combined with significant lower
levels of ferritin in in-attentive type, significantly lower
levels of ferritin and magnesium in hyperactive type and
significantly lower levels of magnesium in combined
type.
Melatonin regulates dopamine function, which is
widely believed to be a key factor in the pathogenesis of
attention-deficit/hyperactivity disorder [16,17]. Higher
Magnetic Resonance Imaging (MRI) of glutamate
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hyperactivity disorder combined with a chelatable zinc
pool in the synapses of these neurons may suggest
higher zinc turnover in this disorder and possibly a
higher zinc requirement in children with attention defi-
cit hyperactivity disorder [18-22].
Oner et al, 2010 [23] reported that low zinc and ferritin
levels were associated with higher hyperactivity symp-
toms in children. This is in accordance with our results
which also in accordance with other studies reported that
serum zinc levels correlate with parent and teacher rated
inattention in children with attention deficit hyperactivity
disorder [22-24].
Iron serves as a cofactor in the synthesis of important
neurotransmitters such as dopamine, nor-epinephrine
and serotonin [10] and deficiency in early years of life
can negatively affect neural and behavioral development
[25,26].
In this study, ferritin was significantly lower in children
with in-attentive and hyperactive types than in controls;
this is consistent with other studies [27,28]. No signifi-
cant difference in ferritin levels was found between
children with combined type and controls, and this is not
in accordance with the previous studies. This may be due
to relatively higher level of hemoglobin in children with
combined type in our study with no significant difference
as regards hemoglobin level between children with com-
bined type and controls.
In agreement with other studies [29,30], magnesium
levels were significantly lower in both children with
hyperactive and combined types than in controls and
this may be due to the role of magnesium in protecting
cell membranes from excitatory neurotransmitters such
as glutamate.
Riley et al, 2008 [31] reported that preschool children
with hyperactive and combined types of attention deficit
hyperactivity disorder demonstrated similar levels of
functioning and they suggested that hyperactive type
may represent an earlier form of combined type. This
supports our results as both children with hyperactive
and combined types were lower in zinc and magnesium
levels than controls.
Bosc et al, 2004 [32]and Mousain et al, 2006 [33]
reported that magnesium/vit.B6 intake reduces central
Table 2 Laboratory data of patients and controls
ITEM Patients
no = 58
Controls
no = 25
p-value
Hb (gm/dl) Range 9.3-13.3 9.9-14.7 0.04*
Mean ± SD 11.8 ± 1.1 12.4 ± 0.9
Zinc (μg/dl). Range 40-180 40-243 0.04*
Mean ± SD 97.5 ± 29.4 117.4 ± 60.2
Ferritin (μg/dl). Range 3-65 7-72 0.03*
Mean ± SD 24.8 ± 14.1 32.6 ± 18.7
Mg (mEq/L). Range 0.7-3.5 0.9-4.3 0.02*
Mean ± SD 1.7 ± 0.8 2.2 ± 0.9
Copper (μg/dl). Range 22-120 23-129 0.9
Mean ± SD 45.4 ± 26.3 45.8 ± 23.05
* = significant
Table 1 Demographic data of the patients and controls
ITEM Patients
no = 58
Controls
no = 25
p-value
Age in years Range 5-13 5-15 0.6
Mean ± SD 8.3 ± 1.8 8.6 ± 3.1
Sex Male 26(44.2%) 12(48%) 0.8
Female 32(55.8%) 13(52%)
Residence Urban 29(50%) 17(68%) 0.1
Rural 29(50%) 8(32%)
Smoking (Paternal or maternal) Positive 48(82.8%) 16(64%) 0.04*
Negative 10(17.2%) 9(36%)
Family history of ADHD Positive 38(65.5%) 4(16%) 0.007**
Negative 20(34.5%) 21(84%)
* = significant
** = highly significant
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tion deficit hyperactivity disorder and this supports our
results as magnesium levels were significantly lower in
both hyperactive and combined types but not in in-
attentive type.
Copper is an essential factor for both the development
and function of the central nervous system. It acts as a
cofactor for several key enzyme systems, most notably
dopamine hydroxylase [34]. In this study, there was no
significant difference between children with attention
deficit hyperactivity disorder and controls as regards
copper levels and this is not in accordance with other
studies which had reported lower levels of copper in
those children [12], nor in accordance with other studies
reported that excess copper may cause hyperactivity,
mood swings, anxiety and anti-social behavior [34].
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Figure 1 Comparison between patients subgroups as regards laboratory data.
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Figure 2 Correlation between zinc and ferritin among patients.
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significantly higher in children with attention deficit
hyperactivity disorder than in controls. This is in accor-
dance with many studies reported that maternal smok-
ing during pregnancy is a risk factor for many cognitive
and behavioral disorders [35,36].
A positive family history of attention deficit hyperactiv-
ity disorder was also significantly higher in patients than
controls and this is in accordance with other studies
which had reported that attention deficit hyperactivity
disorder shares familial and genetic factors [37,38].
Smidts et al, 2007[ 3 9 ]r e p o r t e dm o r ep r e v a l e n c eo f
attention deficit hyperactivity disorder in boys than girls
while Dong et al, 2008 [40] reported the reverse. This
study showed no significant difference between girls and
boys or between rural and urban children. This may be
attributed to the selection of our controls whose age, sex
and socioeconomic state were matched with patients.
Limitations of this study included the small sample of
patients - only 58 children - but this may be attributed to
Egyptian culture which consider regular visits of neurop-
sychiatry unit is shameful as well as low incidence of
attention deficit hyperactivity disorder in general.
Conclusions
Children with attention deficit hyperactivity disorder had
lower levels of zinc, ferritin and magnesium than healthy
controls but had normal copper levels. Zinc levels were
significantly lower in all types of attention deficit hyper-
activity disorder while ferritin levels were significantly
lower in both in-attentive and hyperactive types. Magne-
sium levels were significantly lower in both hyperactive
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Figure 3 Correlation between zinc and magnesium among patients.
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Figure 4 Correlation between magnesium and ferritin among patients.
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may be beneficial in treatment of children with attention
deficit hyperactivity disorder according to their types.
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